Hyperhidrosis: evolving concepts and a comprehensive review
- PMID: 20709287
- DOI: 10.1016/j.surge.2010.06.002
Hyperhidrosis: evolving concepts and a comprehensive review
Abstract
Hyperhidrosis (primary or secondary) describes a disorder of excessive sweating. It has a significant negative impact on quality of life and affects nearly 1% of the population living in the United Kingdom (UK). Axillary involvement is the most common affecting 80% of cases. A common link to these disorders is an extreme non-thermoregulatory sympathetic stimulus of exocrine sweat glands, mostly due to emotional stimuli. Non-surgical treatment involves topical medication, iontophoresis and systemic anti-cholinergics. More recently the use of intradermal botulinum toxin has gained popularity. Surgical treatment reserved for severe cases, not responding to conservative management involves local excision, curettage and thoracoscopic sympathectomy. Evolving concepts for treatment, risks and benefits are discussed in the paper herein.
Crown Copyright © 2010. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.Ann Vasc Surg. 2009 Jan-Feb;23(1):1-7. doi: 10.1016/j.avsg.2008.04.014. Epub 2008 Jul 10. Ann Vasc Surg. 2009. PMID: 18619780
-
Hyperhidrosis: evolving therapies for a well-established phenomenon.Mayo Clin Proc. 2005 May;80(5):657-66. doi: 10.4065/80.5.657. Mayo Clin Proc. 2005. PMID: 15887434 Review.
-
Current therapeutic strategies for hyperhidrosis: a review.Eur J Dermatol. 2002 May-Jun;12(3):219-23. Eur J Dermatol. 2002. PMID: 11978559 Review.
-
[Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A].Schweiz Med Wochenschr. 2000 Jul 25;130(29-30):1084-90. Schweiz Med Wochenschr. 2000. PMID: 10971942 Review. German.
-
Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.J Am Acad Dermatol. 2007 Aug;57(2):207-12. doi: 10.1016/j.jaad.2007.01.035. Epub 2007 Mar 26. J Am Acad Dermatol. 2007. PMID: 17368632
Cited by
-
Botulinum Toxin-loaded Detachable Dissolvable Microneedles for Primary Axillary Hyperhidrosis: A Pilot Study on Efficacy and Safety.J Clin Aesthet Dermatol. 2025 Jan;18(1):E61-E66. J Clin Aesthet Dermatol. 2025. PMID: 39830825 Free PMC article.
-
Efficacy of botulinum toxin injection using the right-sided unilateral retrocrural approach for celiac plexus in a cancer survivor with persistent abdominal pain: a case report.J Int Med Res. 2024 Aug;52(8):3000605241270677. doi: 10.1177/03000605241270677. J Int Med Res. 2024. PMID: 39175230 Free PMC article.
-
Wearable Sweat Loss Measuring Devices: From the Role of Sweat Loss to Advanced Mechanisms and Designs.Adv Sci (Weinh). 2022 Jan;9(1):e2103257. doi: 10.1002/advs.202103257. Epub 2021 Oct 28. Adv Sci (Weinh). 2022. PMID: 34713981 Free PMC article. Review.
-
[Dermatological diseases and their importance for psychiatry].Nervenarzt. 2017 Mar;88(3):254-267. doi: 10.1007/s00115-016-0082-4. Nervenarzt. 2017. PMID: 26975652 Review. German.
-
The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).Qual Life Res. 2015 Apr;24(4):1017-27. doi: 10.1007/s11136-014-0825-2. Epub 2014 Nov 1. Qual Life Res. 2015. PMID: 25367139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources